Learn about the indications of Moboxetinib Capsules.

Mobocertinib is an oral tyrosine kinase inhibitor indicated for the treatment of patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutation-positive metastatic non-small cell lung cancer (mNSCLC). Mobosetinib is indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with an EGFR exon 20 insertion mutation identified by a U.S. Food and Drug Administration (FDA) test and whose disease has progressed during or after platinum-based chemotherapy. This indication received accelerated approval based on overall response rate and duration of response.

EGFR regulates signaling pathways in controlling cell proliferation, and EGFR mutations are associated with non-small cell lung cancer. Mobosetinibis the first and only approved oral therapy designed to specifically bind and inhibitEGFR exon 20 insertion mutations. Mobosetinib capsules are taken orally once daily with or without food. Common side effects of moboxetinib include diarrhea, rash, nausea, stomatitis, vomiting, decreased appetite, paronychia, fatigue, dry skin, musculoskeletal pain, and laboratory abnormalities.

Mobosetinib The original drug is currently on the market in China and has not yet been included in the medical insurance. SpecificationThe price of 40mg*112 pills per box is about 40,000 yuan, which is very expensive.The Hong Kong version of the original drug Specifications40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib have also been put on the market for sale overseas. The drug ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory40mg*120 pills per boxThe pricemay be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.